ResearcherWest China Hospital of Sichuan UniversityActive in the last 2 years

Bing Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-3990-1933; OpenAlex author ID A5039114279. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcom… Last author DOI 10.1096/fj.202302484rr ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qiangxing Chen · 1 shared paper, 2024 · strength 0.18
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr ↗
Ke Cheng · 1 shared paper, 2024 · strength 0.18
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr ↗
Xin Wang · 1 shared paper, 2024 · strength 0.18
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr ↗
Zhong Wu · 1 shared paper, 2024 · strength 0.18
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.